Medicare FFS ophthalmology
Provider service volume comparison
Compare two ophthalmology providers by CY2023 Medicare FFS service volume and CPT/HCPCS mix.
Ashkan M Abbey, M.D.
NPI 1548402886 | Dallas, TX
- National rank
- #27
- Total services
- 129,794
Choose provider
No provider selected.
Search providersCPT/HCPCS service volume comparison
Rows compare visible public provider-service lines by Medicare FFS service count.
| CPT/HCPCS | Description | Provider A services | Provider B services | Absolute difference | Higher Medicare FFS service volume |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 108,194 | 0 | 108,194 | Provider A higher |
| 92134 | Imaging of retina | 4,397 | 0 | 4,397 | Provider A higher |
| 92014 | Established patient complete exam of visual system | 3,862 | 0 | 3,862 | Provider A higher |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3,004 | 0 | 3,004 | Provider A higher |
| 67028 | Injection of drug into eye | 2,655 | 0 | 2,655 | Provider A higher |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 1,956 | 0 | 1,956 | Provider A higher |
| J0178 | Injection, aflibercept, 1 mg | 1,299 | 0 | 1,299 | Provider A higher |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 826 | 0 | 826 | Provider A higher |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 489 | 0 | 489 | Provider A higher |
| J7313 | Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg | 418 | 0 | 418 | Provider A higher |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 353 | 0 | 353 | Provider A higher |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 330 | 0 | 330 | Provider A higher |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 220 | 0 | 220 | Provider A higher |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 180 | 0 | 180 | Provider A higher |
| 92250 | Photography of the retina | 164 | 0 | 164 | Provider A higher |
| J3590 | Unclassified biologics | 155 | 0 | 155 | Provider A higher |
| 76512 | 2d ultrasound scan of eye tissue and structures | 98 | 0 | 98 | Provider A higher |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 98 | 0 | 98 | Provider A higher |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | 87 | 0 | 87 | Provider A higher |
| 92136 | Measurement of corneal curvature and depth of eye | 82 | 0 | 82 | Provider A higher |
| J3490 | Unclassified drugs | 60 | 0 | 60 | Provider A higher |
| 66986 | Exchange of prosthetic lens | 51 | 0 | 51 | Provider A higher |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | 38 | 0 | 38 | Provider A higher |
| J7999 | Compounded drug, not otherwise classified | 32 | 0 | 32 | Provider A higher |
| J9035 | Injection, bevacizumab, 10 mg | 26 | 0 | 26 | Provider A higher |
| 0465T | Injection of medication into space above choroid membrane of eye | 25 | 0 | 25 | Provider A higher |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | 24 | 0 | 24 | Provider A higher |
| 92012 | Established patient problem focused exam of visual system | 24 | 0 | 24 | Provider A higher |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | 22 | 0 | 22 | Provider A higher |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | 15 | 0 | 15 | Provider A higher |
| 66821 | Removal of recurring cataract in lens capsule using a laser | 11 | 0 | 11 | Provider A higher |